INTENT Study Logo
  • About the Study
  • Learn More
  • Our Team
  • Take the Screener
  • Contact Our Study Team
Menu
  • About the Study
  • Learn More
  • Our Team
  • Take the Screener
  • Contact Our Study Team

Author: istudy

Questions? Contact us at theintentstudy@duke.edu

The INTENT Study is funded by Before Brands, the inventor of SpoonfulONE.
The Duke Clinical Research Institute, which is part of Duke University, is coordinating the study operations.
 

 

INTENT Study Logo

*For most infants with severe eczema and/or egg allergy who are already eating solid foods, introducing foods containing ground peanuts between 4 and 10 months of age and continuing consumption may reduce the risk of developing peanut allergy by 5 years of age. FDA has determined, however, that the evidence supporting this claim is limited to one study. If an infant has severe eczema and/or egg allergy, parents are advised to check with the infant’s healthcare provider before feeding foods containing ground peanuts.

WARNING: Do not give SpoonfulOne to a child if the child has a food allergy or is allergic to any ingredient.

References to expert guidelines, professional organizations, or third-party researchers do not constitute or imply the endorsement by such parties of Before Brands’ products.

© 2021 All Rights Reserved